
Ensoma
Operator of a biotech company intended to develop a genomic medicine in vivo approach to engineer any or all blood and immune cells to cure diseases. The company focuses on engineered vectors that per...
Valuation
$0
Share Price
N/A
Total Raised
$258M
Last Round
N/A